Caplin Point Laboratories Share Price

  • 2,152.60-10.00 (-0.47%)
  • Volume: 49,326
  • Closed
  • Last Updated On: 30 May, 2025, 03:57 PM IST
Loading...
Caplin Point Laboratories Share Price
  • 2,152.60-10.00 (-0.47%)
  • Volume: 49,326
Advertisment
Stock Recommendations
  • Potential
    Upside

  • 1 Year
    Target

STRONG BUY

Mean Recos by
2 Analysts

0

0

0

1

1

Strong Sell

Sell

Hold

Buy

Strong Buy

Unlock Potential Upside
Stock Reports Plus

/10

Stock Score

View Report
Earnings
Fundamentals
Relative Valuation
Risk
Price Momentum
No Rating (NR)
Negative
Neutral
Positive
Unlock Stock Score

Caplin Point share price insights

  • Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

  • Caplin Point Laboratories Ltd. share price moved down by -0.47% from its previous close of Rs 2,162.60. Caplin Point Laboratories Ltd. stock last traded price is 2,152.60

    Share PriceValue
    Today/Current/Last2,152.60
    Previous Day2,162.602,161.85

InsightsCaplin Point

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    30.51
    EPS - TTM
    (₹)
    70.55
    MCap
    (₹ Cr.)
    16,362.28
    Sectoral MCap Rank
    33
    PB Ratio
    (x)
    5.70
    Div Yield
    (%)
    0.14
    Face Value
    (₹)
    2.00
    Beta

    Beta

    1 Month0.90
    3 Months1.15
    6 Months1.07
    1 Year1.12
    3 Years1.25

    0.90
    VWAP
    (₹)
    2,160.95
    52W H/L
    (₹)
    2,641.00 / 1,225.00

    Caplin Point Share Price Returns

    1 Day-0.47%
    1 Week-1.83%
    1 Month14.57%
    3 Months18.11%
    1 Year66.68%
    3 Years184.38%
    5 Years572.27%

    ET Stock ScreenersTop Score Companies

    Check whether Caplin Point belongs to analysts' top-rated companies list?

    View Stock Screeners

    Caplin Point Share Recommendations

    Recent Recos

    STRONG BUY

    Current

    Mean Recos by 2 Analysts

    Strong
    Sell
    SellHoldBuyStrong
    Buy
    • Target₹957
    • OrganizationHDFC Securities
    • BUY
    • Target₹540
    • OrganizationICICI Direct
    • BUY

    Analyst Trends

    RatingsCurrent1 Week Ago1 Month Ago3 Months Ago
    Strong Buy1111
    Buy1111
    Hold----
    Sell----
    Strong Sell----
    # Analysts2222

    Caplin Point Financials

    • Insights

      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income528.19524.32503.87477.52470.51
      Total Income Growth (%)0.744.065.521.493.94
      Total Expenses351.43346.87335.10323.11324.39
      Total Expenses Growth (%)1.313.513.71-0.395.62
      EBIT176.76177.45168.77154.41146.12
      EBIT Growth (%)-0.395.149.305.670.38
      Profit after Tax (PAT)142.57138.96130.80123.97121.59
      PAT Growth (%)2.606.245.511.963.75
      EBIT Margin (%)33.4733.8433.4932.3431.06
      Net Profit Margin (%)26.9926.5025.9625.9625.84
      Basic EPS (₹)18.7518.2817.2216.3216.01
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income214.86214.06250.94207.14175.56
      Total Income Growth (%)0.37-14.7021.1517.9916.47
      Total Expenses104.66113.85116.26110.4488.63
      Total Expenses Growth (%)-8.07-2.075.2724.6116.21
      EBIT110.20100.21134.6896.7086.93
      EBIT Growth (%)9.97-25.5939.2811.2416.75
      Profit after Tax (PAT)86.5074.71105.7472.5469.88
      PAT Growth (%)15.78-29.3545.773.8126.02
      EBIT Margin (%)51.2946.8153.6746.6849.52
      Net Profit Margin (%)40.2634.9042.1435.0239.80
      Basic EPS (₹)11.379.8313.929.559.20
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue2,033.901,761.041,522.711,308.161,084.83
      Total Revenue Growth (%)15.4915.6516.4020.5919.93
      Total Expenses1,357.111,196.881,071.44922.34771.21
      Total Expenses Growth (%)13.3911.7116.1719.6021.44
      Profit after Tax (PAT)536.31457.09376.26299.84242.27
      PAT Growth (%)17.3321.4825.4923.7612.68
      Operating Profit Margin (%)34.9633.3430.8230.4429.70
      Net Profit Margin (%)27.6826.9825.6523.6222.82
      Basic EPS (₹)70.5760.1949.6239.6132.03
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue887.00730.93627.61584.61501.30
      Total Revenue Growth (%)21.3516.467.3616.62-15.58
      Total Expenses445.33365.19334.46334.30291.36
      Total Expenses Growth (%)21.949.190.0514.74-14.47
      Profit after Tax (PAT)339.49283.71234.26187.87156.22
      PAT Growth (%)19.6621.1124.6920.26-20.96
      Operating Profit Margin (%)58.7158.5255.4747.4143.52
      Net Profit Margin (%)45.1245.3844.3135.5732.36
      Basic EPS (₹)44.6737.3630.8924.8220.65

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3,208.582,698.122,191.401,736.321,363.61
      Total Assets Growth (%)18.9223.1226.2127.3321.13
      Total Liabilities322.19351.29284.13226.44160.25
      Total Liabilities Growth (%)-8.2823.6425.4841.31-5.28
      Total Equity2,886.392,272.251,832.691,435.301,203.36
      Total Equity Growth (%)27.0323.9827.6919.2736.44
      Current Ratio (x)6.975.715.806.257.25
      Total Debt to Equity (x)0.000.000.000.000.01
      Contingent Liabilities0.00115.03257.94124.6662.15
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets1,814.481,522.311,303.181,054.16861.00
      Total Assets Growth (%)19.1916.8223.6222.4324.54
      Total Liabilities113.55132.16163.27123.51102.33
      Total Liabilities Growth (%)-14.08-19.0532.1920.7011.93
      Total Equity1,700.931,390.151,139.91930.65758.67
      Total Equity Growth (%)22.3621.9522.4922.6726.46
      Current Ratio (x)8.275.894.526.136.89
      Total Debt to Equity (x)0.000.000.000.000.00
      Contingent Liabilities0.0036.9984.6036.8144.61

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Increase in Cash from Investing

        Company has used Rs 334.73 cr for investing activities which is an YoY increase of 4.59%. (Source: Consolidated Financials)
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities432.36318.39271.37336.75265.77
      Net Cash used in Investing Activities-334.73-320.04-217.58-270.94-5.36
      Net Cash flow from Financing Activities-38.32-38.07-28.17-40.71-23.98
      Net Cash Flow59.31-39.0126.8025.01236.20
      Closing Cash & Cash Equivalent198.02138.55177.56460.73456.96
      Closing Cash & Cash Equivalent Growth (%)42.92-21.97-61.460.82106.99
      Total Debt/ CFO (x)0.000.000.010.000.06
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities195.87111.01157.10230.97294.65
      Net Cash used in Investing Activities-140.20-118.94-86.67-237.1816.28
      Net Cash flow from Financing Activities-38.10-34.26-30.42-22.76-3.46
      Net Cash Flow19.00-41.3841.01-29.06307.28
      Closing Cash & Cash Equivalent99.6480.64122.02313.82362.88
      Closing Cash & Cash Equivalent Growth (%)23.56-33.91-61.12-13.52552.58
      Total Debt/ CFO (x)0.000.000.000.000.00

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)18.8120.3920.8321.2720.43
      Return on Capital Employed (%)23.3423.8623.5025.2825.82
      Return on Assets (%)16.7116.9417.1617.2617.76
      Interest Coverage Ratio (x)1,218.62792.79637.23619.17198.29
      Asset Turnover Ratio (x)0.660.690.750.4477.82
      Price to Earnings (x)28.4121.9312.0517.2112.63
      Price to Book (x)5.344.462.513.662.58
      EV/EBITDA (x)19.7315.348.1810.887.47
      EBITDA Margin (%)38.3636.5033.8834.1433.18
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)19.9520.4020.5520.1820.59
      Return on Capital Employed (%)25.7626.0725.3626.2126.81
      Return on Assets (%)18.7118.6317.9717.8218.14
      Interest Coverage Ratio (x)3,888.003,929.202,657.673,068.561,260.36
      Asset Turnover Ratio (x)0.450.440.450.5556.06
      Price to Earnings (x)44.8435.3419.3427.4719.57
      Price to Book (x)8.957.203.975.544.03
      EV/EBITDA (x)32.1624.9113.3517.5211.57
      EBITDA Margin (%)62.0062.8560.3352.2948.17

    Financial InsightsCaplin Point

    • Income (P&L)
    • Cash Flow
      • Quarterly Topline Performance

        Company witnessed QoQ revenue decline of 0.74%, which is lowest in the last 3 years. (Source: Consolidated Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 9.17% towards employee cost in the year ending Mar 31, 2025. (Source: Consolidated Financials)

      • Increase in Cash from Investing

        Company has used Rs 334.73 cr for investing activities which is an YoY increase of 4.59%. (Source: Consolidated Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Caplin Point Share Price Forecast

    • Get multiple analysts’ prediction on Caplin Point

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Caplin Point

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL
    • Get multiple analysts’ prediction on Caplin Point

      Stock Forecast Non Prime User
      • High, low, medium predictions for Price
      • Upcoming predictions for Revenue
      • Details about company earnings
      START FREE TRIAL

    Caplin Point Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • 41%
      Positive Movement since
      1st Jan 2005 on basis
      58%
      Negative Movement since
      1st Jan 2005 on basis
      Exclude
    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR83.8484.9989.45

    Caplin Point Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Caplin Point30.515.6718.8123.3416.7115.6834.9627.9270.576.970.000.00
      Eris Lifesciences61.156.5812.3212.745.0028.1624.8812.9425.850.910.872.33
      Alembic Pharma34.303.8611.2314.407.507.7411.578.7129.681.690.2313.59
      Jubilant Life22.273.0013.418.136.585.8311.9111.5652.991.650.392.27
      Aarti Inds51.383.045.907.592.976.117.994.559.130.840.683.05
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Natco Pharma
      • Blue Jet Healthcare
      • Neuland Labs
      • Granules India
      • Glenmark Life

      Choose from Stocks

      Peers InsightsCaplin Point

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Caplin Point Shareholding Pattern

        • Loading...
          Showing Caplin Point Shareholding as on Mar 2025
          CategoryMar 2025Dec 2024Sep 2024Jun 2024
          Promoters70.5670.5670.5670.56
          Pledge0.000.000.000.00
          FII5.724.863.713.38
          DII2.002.111.831.49
          Mutual Funds1.741.861.621.32
          Others21.7222.4723.9024.57
        • Showing Shareholding as on Mar 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters5,36,32,98270.56 %0.00
          Pledge00.00 %0.00
          FII43,55,7045.72 %0.86
          DII15,23,0252.00 %-0.11
          MF13,23,9031.74 %-0.12
          Others1,64,99,98521.72 %-0.75

        Caplin Point MF Ownership

        MF Ownership as on 30 April 2025

        Caplin Point Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          May 15, 2025May 07, 2025Board MeetingAudited Results & Interim Dividend
          Feb 07, 2025Jan 31, 2025Board MeetingQuarterly Results
          Nov 07, 2024Oct 30, 2024Board MeetingQuarterly Results
          Sep 30, 2024Aug 07, 2024AGMBook closure from Sep 24, 2024 to Sep 30, 2024
          Aug 07, 2024Jul 31, 2024Board MeetingQuarterly Results & Final Dividend
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final150%3.0May 30, 2025May 15, 2025
          Interim150%3.0May 30, 2025May 15, 2025
          Final125%2.5Sep 23, 2024Aug 07, 2024
          Interim125%2.5May 31, 2024May 16, 2024
          Final125%2.5Sep 14, 2023Aug 07, 2023
        • All TypesEx-DateRecord DateAnnounced onDetails
          SplitsOct 19, 2016Oct 20, 2016Aug 05, 2016Split: Old FV10.0| New FV:2.0

        About Caplin Point

        Caplin Point Laboratories Ltd., incorporated in the year 1990, is a Small Cap company (having a market cap of Rs 16,362.28 Crore) operating in Pharmaceuticals sector. Caplin Point Laboratories Ltd. key Products/Revenue Segments include Pharmaceutical Products and Export Incentives for the year ending 31-Mar-2024. Show More

        • Executives

        • Auditors

        • CC

          C C Paarthipan

          Chairman
          SG

          Sridhar Ganesan

          Managing Director
          CK

          C K Gariyali

          Independent Director
          DS

          D Sathyanarayanan

          Independent Director
          Show More
        • Brahmayya & Co.
          CNGSN & Associates LLP

        Key Indices Listed on

        Nifty 500, BSE 500, BSE 250 SmallCap Index, + 15 more

        Address

        3rd Floor, Ashvich Towers,No.3, Developed Plots IndustrialEstate, Perungudi,Chennai (Madras), Tamil Nadu - 600096

        FAQs about Caplin Point share

        • 1. What's Caplin Point share price today and what are Caplin Point share returns ?
          Caplin Point share price is Rs 2,152.60 as on 30 May, 2025, 03:55 PM IST. Caplin Point share price is down by 0.47% based on previous share price of Rs. 2146.0. In last 1 Month, Caplin Point share price moved up by 14.57%.
        • 2. What is the PE & PB ratio of Caplin Point?
          The PE ratio of Caplin Point stands at 30.65, while the PB ratio is 5.69.
        • 3. Who's the chairman of Caplin Point?
          C C Paarthipan is the Chairman of Caplin Point
        • 4. What is 52 week high/low of Caplin Point share price?
          Caplin Point share price saw a 52 week high of Rs 2,641.00 and 52 week low of Rs 1,225.00.
        • 5. What's the market capitalization of Caplin Point?
          Market Capitalization of Caplin Point stock is Rs 16,362.28 Cr.
        • 6. What is the recommendation for Caplin Point - Buy or Sell?
          As per Refinitiv (erstwhile Thomson Reuters), overall mean recommendation by 2 analysts for Caplin Point stock is to Strong Buy. Recommendation breakup is as follows
          • 1 analyst is recommending Strong Buy
          • 1 analyst is recommending to Buy
        • 7. What is the CAGR of Caplin Point?
          The CAGR of Caplin Point is 11.15.
        • 8. What are the Caplin Point quarterly results?
          On Consoldiated basis, Caplin Point reported a total income and profit of Rs 528.19 Cr and Rs 142.57 respectively for quarter ending 2025-03-31. Total Income and profit for the year ending 2025-03-31 was Rs 2033.90 Cr and Rs 536.31 Cr.
        • 9. Who are the peers for Caplin Point in Pharmaceuticals sector?
          Top 10 Peers for Caplin Point are Jubilant Pharmova Ltd., Aarti Industries Ltd., Alembic Pharmaceuticals Ltd., Alivus Life Sciences Ltd., Neuland Laboratories Ltd., Blue Jet Healthcare Ltd, Granules India Ltd., Eris Lifesciences Ltd., Marksans Pharma Ltd. and Natco Pharma Ltd.
        • 10. What are the returns for Caplin Point share?
          Return Performance of Caplin Point Shares:
          • 1 Week: Caplin Point share price moved down by 1.83%
          • 1 Month: Caplin Point share price moved up by 14.57%
          • 3 Month: Caplin Point share price moved up by 18.11%
          • 6 Month: Caplin Point share price moved down by 1.99%
        • 11. Is Caplin Point giving dividend?
          An equity Final dividend of Rs 3 per share was declared by Caplin Point Laboratories Ltd. on 15 May 2025. So, company has declared a dividend of 150% on face value of Rs 2 per share. The ex dividend date was 30 May 2025.
        • 12. Who's the owner of Caplin Point?
          Promoter, DII and FII owns 70.56, 2.11 and 4.86 shares of Caplin Point as on 31 Mar 2025
          • There is no change in promoter holding from 31 Dec 2024 to 31 Mar 2025
          • Domestic Institutional Investors holding have gone down from 2.11 (31 Dec 2024) to 2.0 (31 Mar 2025)
          • Foreign Institutional Investors holding has gone up from 4.86 (31 Dec 2024) to 5.72 (31 Mar 2025)
          • Other investor holding have gone down from 22.47 (31 Dec 2024) to 21.72 (31 Mar 2025)
        • 13. How can I quickly analyze Caplin Point stock?
          Caplin Point share can be quickly analyzed on following metrics:
          • Stock's PE is 30.51
          • Price to Book Ratio of 5.70

        Trending in Markets

        Top Gainers As on 03:59 PM | 30 May 2025

        MMTC85.77
        22.09 (34.69%)
        ITI Ltd346.60
        67.85 (24.34%)
        Welspun Corp935.55
        173.50 (22.77%)
        IFCI67.42
        12.16 (22.01%)
        GE T&D India 2,241.40
        356.30 (18.90%)

        Top Losers As on 03:59 PM | 30 May 2025

        Welspun India132.66
        -19.40 (-12.76%)
        Gujarat Fluorochem3,553.30
        -472.50 (-11.74%)
        Chambal Fertilisers551.00
        -43.30 (-7.29%)
        Balkrishna Ind.2,472.20
        -188.00 (-7.07%)
        Godawari Power190.48
        -14.31 (-6.99%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times
        OSZAR »